Provided by Tiger Trade Technology Pte. Ltd.

Medpace

602.70
-1.5500-0.26%
Post-market: 602.700.00000.00%16:52 EDT
Volume:223.09K
Turnover:133.39M
Market Cap:16.82B
PE:35.33
High:604.56
Open:602.43
Low:590.46
Close:604.25
52wk High:677.90
52wk Low:373.00
Shares:27.91M
Float Shares:22.58M
Volume Ratio:0.85
T/O Rate:0.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.06
EPS(LYR):15.28
ROE:162.15%
ROA:20.10%
PB:38.77
PE(LYR):39.44

Loading ...

Medpace Outlook FY EPS USD 17.25-17.95

THOMSON REUTERS
·
Jul 23

U.S. Earnings Preview: After Market Close July 22

Dow Jones
·
Jul 23

Medpace Backs Phase 2 Cancer Imaging Trial With [68Ga]BED003

TIPRANKS
·
Jul 16

Earning Preview: Medpace revenue is expected to increase by 27.83%, institutional views are broadly positive

Earnings Agent
·
Jul 15

Medpace Holdings Inc : Mizuho Raises Target Price to $586 from $495

THOMSON REUTERS
·
Jul 13

TD Cowen Sees Improving Demand for Contract Research Firms in Q2 2026

Reuters
·
Jul 09

Baird Downgrades Medpace to Neutral From Outperform, Adjusts PT to $547 From $477

MT Newswires Live
·
Jul 08

Medpace downgraded to Neutral from Outperform at Baird

TIPRANKS
·
Jul 08

Medpace Shares Fall After Jefferies Downgrade

MT Newswires Live
·
Jul 08

Jefferies Downgrades Medpace Holdings to Hold From Buy, Adjusts Price Target to $515 From $490

MT Newswires Live
·
Jul 07

Medpace Holdings Cut to Hold from Buy by Jefferies

Dow Jones
·
Jul 07

Medpace Holdings Inc : Jefferies Cuts to Hold from Buy; Raises Target Price to $515 from $490

THOMSON REUTERS
·
Jul 07

Movement Alert|Medpace Holdings Rises 7.2% in Regular Trading, Trading at $507.6

Market Focus
·
Jun 25

Medpace to report second-quarter results after market close, host conference call to discuss results

Reuters
·
Jun 17

Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026

THOMSON REUTERS
·
Jun 17

Medpace Holdings (MEDP) Stock Valuation Check After Mixed Recent Share Performance

Simply Wall St.
·
Jun 16

Pritelivir Trial Update Highlights Medpace’s Role in Drug-Resistant HSV Market

TIPRANKS
·
Jun 13

How Investors Are Reacting To Medpace Holdings (MEDP) Executive Shakeup Amid Securities Class Action Surge

Simply Wall St.
·
Jun 08

Medpace Elevates Brad Hansman to Executive Operations Role

TIPRANKS
·
Jun 05

Medpace says Exec VP of Operations Brad W. Hansman files initial beneficial ownership statement

Reuters
·
Jun 05